Invesaro

Stocks TLPH Financial statements

Financial statements

TALPHERA, INC. financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data TALPHERA, INC. files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue17.482.152.295.422.8200.6500.03
Cost of revenue12.310.73.986.816.033.752.59
Gross profit5.04-2.66-1.83-4.52-0.62-0.94-2.59
Research and development21.419.413.14.664.024.13.345.556.726.03
Selling, general and administrative16.620.84536.330.917128.537.48
General and administrative15.616.620.8
Operating expenses49.346.737.9
Operating income-32-38.7-35.7-54.2-41-36-25.3-16.9-15.3-13.5
Interest expense2.773.322.222.543.312.291.120.130
Other non-operating income-11.2-13.5-11.40.970.590.8784.46.62.25-0.88
Pre-tax income-43.2-52.2-47.1-53.2-40.4-35.159.1-10.3
Income tax-0.03-0.70000.010.01000
Income from continuing operations59.1-10.3-13-14.4
Net income-43.2-51.5-47.1-53.2-40.4-35.147.8-18.4-13-14.3
EBITDA-29.9-36.9-35.2-52.5-39.1-34-23.7-16.6-15.3
EPS, basic-19.20-22.23-16.37-13.54-9.50-5.865.73-1.29-0.50-0.34
EPS, diluted-19.20-22.23-16.37-13.54-9.50-5.865.72-1.29-0.50-0.34
Shares, basic (weighted)2.242.322.893.924.225.997.3914.325.842.4
Shares, diluted (weighted)2.242.322.893.924.225.997.4114.325.842.4

Balance sheet

FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash and equivalents80.352.98814.722.37.6615.35.728.865.89
Short-term investments7.5717.751.515.6390.53.66014.5
Receivables5.831.530.050.430.640.160.31
Inventory2.150.960.853.31.631.111.18
Other current assets0.760.461.021.821.682.591.872.20.550.52
Total current assets89.163.410871.746.850.524.611.69.4220.9
Property, plant and equipment10.711.111.514.615.715.910.3
Lease right-of-use assets3.933.154.30.1
Intangible assets08.828.828.828.82
Other non-current assets0.050.210.711.190.662.170.170.02
Total assets10075.612191.466.377.947.520.418.229.7
Accounts payable1.561.422.071.722.742.121.261.340.670.54
Accrued liabilities4.63.544.545.535.056.522.532.451.252.62
Deferred revenue0.360.360.320.410.05
Short-term debt2.917.738.614.638.748.85.360
Total current liabilities10.213.715.913.617.618.513.84.512.653.81
Long-term debt18.611.43.3820.513.15.010
Lease liabilities3.642.613.752.96
Other non-current liabilities0.540.490.30.080.810
Total liabilities10511211613312211425.76.2910.212.7
Total debt21.519.11225.121.913.85.760
Paid-in capital241261349357383438448458465489
Retained earnings-246-298-345-398-438-474-426-444-457-472
Other comprehensive income0
Shareholders' equity-5.34-36.54.25-41.4-55.8-35.921.814.1817
Total equity-5.34-36.54.25-41.4-55.8-35.921.814.1817
Total liabilities and equity10075.612191.466.377.947.520.418.229.7
Shares outstanding2.242.523.93.944.896.848.24171749.3

Cash flow statement

FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Net income-43.2-51.5-47.1-53.2-40.4-35.147.8-18.4-13-14.3
Depreciation and amortization2.051.740.581.671.851.971.650.310
Stock-based compensation4.484.295.175.064.424.612.891.730.990.7
Deferred income tax-0
Change in receivables-2.554.31.48-0.38-0.20.48-0.15-0.19
Change in inventory-1.690.920.1-3.390.96-0.3-0.110.060
Change in payables-0.440.310.46-0.021.020.110.55-0.58-0.67-0.21
Cash from operations-29.4-29.8-29.1-51.2-38.5-30-28.3-17.5-12.7-11.4
Capital expenditures-3.72-2.41-0.82-3.47-1.86-1.83-0.36-0.10
Acquisitions-0.82-1.690
Purchases of investments-1-7.57-30.6-100-44.6-70.5-7.86-3.65-4.98-17.8
Sales and maturities of investments6.5320.5670300.58.763.46
Cash from investing1.81-9.97-10.9-36.634.1-26.136.5-0.533.78-14.3
Debt issued0250
Debt repaid-3.51-7.72-3.47-4.67-8.83-8.43-5.420
Stock issued15.781.51.2321.344.7
Cash from financing-0.0312.37514.51741.5-0.513.471222.7
Net change in cash-27.6-27.435.1-73.312.6-14.67.61-14.63.14-2.97
Free cash flow-33.1-32.2-29.9-54.7-40.4-31.8-28.7-17.6-12.7
Interest paid1.892.041.671.712.271.60.820.120
Income taxes paid-0.0600-0.35-0.350.010.0100

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $1.18 on September 25, 2026.

Profitability

MetricValueHow it is calculated
Operating margin-1,474,700.0%Operating income / revenue.
Net margin-1,507,600.0%Net income / revenue.
Operating cash flow margin-1,227,000.0%Cash from operations / revenue.
Return on equity (ROE)-104.7%Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)-56.2%Net income / average total assets.
Return on invested capital (ROIC)-85.3%Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
R&D / revenue670,400.0%Research and development expense / revenue.
SG&A / revenue804,400.0%Selling, general and administrative expense / revenue.
Stock-based pay / revenue79,400.0%Stock-based compensation (from the cash flow statement) / revenue.

Growth

MetricValueHow it is calculated
Revenue CAGR, 5y-65.1%Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y112.9%Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y-7.9%Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets growth, 1y63.0%Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y-14.5%Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y-14.8%Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y64.1%Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y78.9%Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y58.7%Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

MetricValueHow it is calculated
Current ratio4.29xCurrent assets / current liabilities.
Quick ratio4.08x(Cash + short-term investments + receivables) / current liabilities.
Cash ratio4.08x(Cash + short-term investments) / current liabilities.
Liabilities / assets46.3%Total liabilities / total assets.
Working capital$13.8MCurrent assets - current liabilities.
Goodwill and intangibles / assets32.9%(Goodwill + intangible assets) / total assets.
Tangible book value$5.6MShareholders' equity - goodwill - intangible assets.

Efficiency

MetricValueHow it is calculated
Asset turnover0.00xRevenue / average total assets.

Per share

MetricValueHow it is calculated
EPS, diluted-$0.20Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share$0.00Revenue / diluted weighted shares.
Operating cash flow per share-$0.16Cash from operations / diluted weighted shares.
Book value per share$0.28Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share$0.11Tangible book value / shares outstanding.
Cash per share$0.33(Cash + short-term investments) / shares outstanding.

Valuation

MetricValueHow it is calculated
Market cap$61.2MShare price x shares outstanding.
Enterprise value$44.2MMarket cap + total debt - cash - short-term investments.
P/S61,249xMarket cap / revenue.
P/B4.25xMarket cap / shareholders' equity. Only when equity is positive.
Price / tangible book11.0xMarket cap / tangible book value, when positive.
EV/Sales44,173xEnterprise value / revenue.
Earnings yield-24.6%Net income / market cap (the inverse of P/E).
What was TALPHERA, INC.'s revenue in fiscal 2025?

TALPHERA, INC. reported revenue of $28.0K for fiscal 2025.

Was TALPHERA, INC. profitable in fiscal 2025?

No. It reported a net loss of $14.3M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to TALPHERA, INC.